Simplex Trading
TERN

Simplex Trading’s Terns Pharmaceuticals TERN Stock Holding History

Simplex Trading’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.42M Buy
121,700
+80,700
+197% +$3.31M ﹤0.01% 947
2025
Q4 		$1.66M Sell
41,000
-28,300
-41% -$654K ﹤0.01% 2134
2025
Q3 		$520K Buy
69,300
+37,600
+119% +$240K ﹤0.01% 3776
2025
Q2 		$118K Sell
31,700
-19,700
-38% -$61.5K ﹤0.01% 5074
2025
Q1 		$141K Buy
51,400
+8,600
+20% +$35.1K ﹤0.01% 4698
2024
Q4 		$237K Sell
42,800
-128,500
-75% -$870K ﹤0.01% 4344
2024
Q3 		$1.43M Buy
171,300
+145,200
+556% +$1.19M ﹤0.01% 2578
2024
Q2 		$177K Buy
26,100
+12,300
+89% +$74.5K ﹤0.01% 4776
2024
Q1 		$90K Sell
13,800
-12,000
-47% -$78.4K ﹤0.01% 5696
2023
Q4 		$167K Buy
25,800
+1,900
+8% +$10K ﹤0.01% 4844
2023
Q3 		$120K Buy
23,900
+13,800
+137% +$87.6K ﹤0.01% 4906
2023
Q2 		$88K Buy
+10,100
New +$118K ﹤0.01% 5243

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Simplex Trading's TERN Position: Q3 2025 in Review

Simplex Trading sold out of Terns Pharmaceuticals (TERN) in Q3 2025, closing a stake of 14,650 shares — an estimated $93.5K sold.

Simplex Trading first reported a position in TERN in Q2 2023 and held it in 5 quarters. The position peaked at $357K in Q2 2023. 141 funds tracked by Wall St. Rank hold TERN as of Q3 2025.

  • Simplex Trading reported no remaining Terns Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 14,650 Terns Pharmaceuticals shares in Q3 2025, an estimated $93.5K.
  • Simplex Trading first reported a position in Terns Pharmaceuticals in Q2 2023 and held it in 5 quarters.
  • Simplex Trading's Terns Pharmaceuticals position peaked at $357K in Q2 2023.
  • 141 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.